We took advantage of a human RKO cell line (p53 wildtype colon carcinoma) harbouring an inducible Cas9 cassette that has been effectively used in various genome-wide CRISPR screens (Fig. 1a)19,20. The gene discussed is TP53; the disease is colon carcinoma.